UpHealth says reverse stock split to effect changes to warrant terms

UpHealth announced that the previously announced reverse stock split of the company’s issued and outstanding common stock approved by its Board of Directors and the company’s stockholders on December 5, 2022 whereby each ten shares of common stock will be combined and reconstituted into one share of common stock will effect proportionate adjustments to its outstanding warrants. The company’s warrants, traded on the NYSE under the symbol UPH.WS, will be reduced at a ratio of 1-for-10. The exercise price of each warrant will increase from $11.50 per share to $115.00 per share.